Sangamo Therapeutics, Inc
SGMOQ- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001001233
No open-market purchases or sales by Sangamo Therapeutics, Inc insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $29.0K in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Sangamo Therapeutics, Inc as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 128
- +26 vs. Q3 2024
- Shares held
- 61.6M
- +5.40M (+9.6%) vs. Q3 2024
- Total value
- $62.9M
- +$14.3M (+29.4%) vs. Q3 2024
- New holders
- 42
- 33 more added
- Sold out
- 16
- 29 more reduced
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SGMOQ on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 6 | $29.0K |
| Q1 2026 | 112 | $26.0M |
| Q4 2025 | 105 | $26.2M |
| Q3 2025 | 112 | $42.1M |
| Q2 2025 | 114 | $39.6M |
| Q1 2025 | 122 | $34.5M |
| Q4 2024 | 128 | $62.9M |
| Q3 2024 | 103 | $48.6M |
| Q2 2024 | 129 | $31.1M |
| Q1 2024 | 131 | $68.2M |
| Q4 2023 | 130 | $47.2M |
| Q3 2023 | 135 | $61.3M |
| Q2 2023 | 152 | $137.4M |
| Q1 2023 | 180 | $197.6M |
| Q4 2022 | 182 | $326.0M |
| Q3 2022 | 197 | $477.2M |
| Q2 2022 | 188 | $371.1M |
| Q1 2022 | 195 | $459.6M |
| Q4 2021 | 193 | $577.0M |
| Q3 2021 | 193 | $679.3M |
| Q2 2021 | 197 | $912.0M |
| Q1 2021 | 203 | $994.7M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Sangamo Therapeutics, Inc; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Marshall Wace, LLP | 337,130 | $343.9K | 0.00% | −2,016,626−85.7% | Reduced |
| Mirae Asset Global ETFs Holdings Ltd. | 328,064 | $353.0K | 0.00% | +328,064 | New |
| Rafferty Asset Management, LLC | 351,337 | $358.4K | 0.00% | +351,337 | New |
| Northern Trust Corp | 398,289 | $406.3K | 0.00% | +17,049+4.5% | Added |
| Macquarie Group Ltd | 400,000 | $408.0K | 0.00% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 456,946 | $466.1K | 0.01% | +456,946 | New |
| Boothbay Fund Management, LLC | 537,219 | $548.0K | 0.02% | +537,219 | New |
| FMR LLC | 578,265 | $589.8K | 0.00% | +34,262+6.3% | Added |
| Two Sigma Advisers, LP | 707,555 | $721.7K | 0.00% | +707,555 | New |
| Squarepoint Ops LLC | 710,363 | $724.6K | 0.00% | +710,363 | New |
| Acuta Capital Partners, LLC | 740,000 | $754.8K | 0.76% | +740,000 | New |
| Jacobs Levy Equity Management, Inc | 742,462 | $757.3K | 0.00% | −729,255−49.6% | Reduced |
| HighTower Advisors, LLC | 756,823 | $772.0K | 0.00% | −36,255−4.6% | Reduced |
| Citadel Advisors LLC | 804,314 | $820.4K | 0.00% | +77,257+10.6% | Added |
| Two Sigma Investments, LP | 1,012,640 | $1.03M | 0.00% | +698,296+222.1% | Added |
| Charles Schwab Investment Management Inc | 1,139,252 | $1.16M | 0.00% | +35,926+3.3% | Added |
| Goldman Sachs Group Inc | 1,606,909 | $1.64M | 0.00% | +1,538,428+2,246.5% | Added |
| Schonfeld Strategic Advisors LLC | 1,709,615 | $1.74M | 0.01% | +1,709,615 | New |
| Ikarian Capital, LLC | 1,860,179 | $1.90M | 0.54% | +1,860,179 | New |
| Morgan Stanley | 1,881,261 | $1.92M | 0.00% | +1,528,514+433.3% | Added |
| Geode Capital Management, LLC | 2,211,849 | $2.26M | 0.00% | +73,540+3.4% | Added |
| Point72 Asset Management, L.P. | 2,270,550 | $2.32M | 0.01% | +2,270,550 | New |
| Millennium Management LLC | 2,739,666 | $2.79M | 0.00% | +828,337+43.3% | Added |
| Renaissance Technologies LLC | 3,084,877 | $3.15M | 0.00% | −1,767,900−36.4% | Reduced |
| State Street Corp | 5,019,035 | $5.12M | 0.00% | +4,354,414+655.2% | Added |
| BlackRock, Inc. | 5,193,304 | $5.30M | 0.00% | +1,564,235+43.1% | Added |
| Wasatch Advisors Inc | 9,231,505 | $9.42M | 0.05% | −10,210,863−52.5% | Reduced |
| Vanguard Group Inc | 9,374,728 | $9.56M | 0.00% | −223,049−2.3% | Reduced |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −363,490−100.0% | Sold out |
| Massachusetts Financial Services Co | 0 | $0 | 0.00% | −193,762−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −172,665−100.0% | Sold out |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −92,000−100.0% | Sold out |
| Unique Wealth, LLC | 0 | $0 | 0.00% | −27,950−100.0% | Sold out |
| Brighton Jones LLC | 0 | $0 | 0.00% | −11,000−100.0% | Sold out |
| New Harbor Financial Group, LLC | 0 | $0 | 0.00% | −10,410−100.0% | Sold out |
| Winthrop Advisory Group LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −1,271−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Planned Solutions, Inc. | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Capital Performance Advisors LLP | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −446−100.0% | Sold out |
| SRS Capital Advisors, Inc. | 0 | $0 | 0.00% | −142−100.0% | Sold out |
| GPS Wealth Strategies Group, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| TD Waterhouse Canada Inc. | 0 | $0 | 0.00% | −31−100.0% | Sold out |
| Raymond James Financial Services Advisors, Inc. | – | – | – | – | Not filed |